HARBIN GLORIA PHARMACEUTICALS Co., LTD (SHE:002437)
China
· Delayed Price · Currency is CNY 2.490
-0.010 (-0.40%)
Apr 29, 2025, 2:45 PM CST
SHE:002437 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 2,399 | 2,441 | 2,619 | 3,103 | 3,131 | 3,038 | Upgrade
|
| Other Revenue | - | - | 7.02 | 5.09 | 14.07 | 17.26 | Upgrade
|
| Revenue | 2,399 | 2,441 | 2,626 | 3,108 | 3,145 | 3,055 | Upgrade
|
| Revenue Growth (YoY) | -5.48% | -7.06% | -15.51% | -1.19% | 2.96% | -39.55% | Upgrade
|
| Cost of Revenue | 1,144 | 1,136 | 1,096 | 1,362 | 832.93 | 850.49 | Upgrade
|
| Gross Profit | 1,255 | 1,305 | 1,530 | 1,746 | 2,312 | 2,204 | Upgrade
|
| Selling, General & Admin | 890.99 | 959.35 | 1,244 | 1,518 | 2,058 | 2,178 | Upgrade
|
| Research & Development | 91.13 | 90.79 | 85.44 | 100.63 | 97.73 | 125.49 | Upgrade
|
| Other Operating Expenses | -1.8 | -37.89 | 29.2 | 41.52 | 41.17 | 38.43 | Upgrade
|
| Operating Expenses | 980.33 | 1,012 | 1,358 | 1,660 | 2,197 | 2,349 | Upgrade
|
| Operating Income | 274.95 | 292.57 | 171.97 | 85.61 | 115.68 | -144.7 | Upgrade
|
| Interest Expense | - | - | -42.65 | -68.67 | -71.48 | -88.55 | Upgrade
|
| Interest & Investment Income | 5.44 | 5.25 | 18.47 | 20.78 | 17.21 | 815.05 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | 1.19 | 13.54 | -3.86 | -11.85 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.87 | 1.32 | -6.47 | -4.19 | -14.1 | -3.09 | Upgrade
|
| EBT Excluding Unusual Items | 281.58 | 299.14 | 142.51 | 47.08 | 43.44 | 566.86 | Upgrade
|
| Impairment of Goodwill | - | - | - | -42.13 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.99 | -13.98 | -41.37 | -269.57 | -9.31 | 11.47 | Upgrade
|
| Gain (Loss) on Sale of Assets | 6.8 | 3.4 | 2.84 | 3.82 | 4.65 | -40.67 | Upgrade
|
| Asset Writedown | -5.13 | -4.87 | -0.28 | -37.32 | -1.84 | -22.76 | Upgrade
|
| Other Unusual Items | - | - | 71.06 | 27.44 | 49.03 | 50.23 | Upgrade
|
| Pretax Income | 284.23 | 283.69 | 176.78 | -269.68 | 85.97 | 565.12 | Upgrade
|
| Income Tax Expense | 35.52 | 41.15 | 48.08 | 19.84 | 32.14 | 156.44 | Upgrade
|
| Earnings From Continuing Operations | 248.71 | 242.54 | 128.7 | -289.52 | 53.84 | 408.68 | Upgrade
|
| Minority Interest in Earnings | -7.98 | -9.78 | -8.37 | -1.81 | -8.8 | -8.63 | Upgrade
|
| Net Income | 240.73 | 232.76 | 120.33 | -291.33 | 45.04 | 400.05 | Upgrade
|
| Net Income to Common | 240.73 | 232.76 | 120.33 | -291.33 | 45.04 | 400.05 | Upgrade
|
| Net Income Growth | 57.79% | 93.43% | - | - | -88.74% | - | Upgrade
|
| Shares Outstanding (Basic) | 2,191 | 2,198 | 2,200 | 2,199 | 2,197 | 2,198 | Upgrade
|
| Shares Outstanding (Diluted) | 2,272 | 2,262 | 2,200 | 2,199 | 2,197 | 2,198 | Upgrade
|
| Shares Change (YoY) | 3.04% | 2.82% | 0.05% | 0.07% | -0.04% | -0.01% | Upgrade
|
| EPS (Basic) | 0.11 | 0.11 | 0.05 | -0.13 | 0.02 | 0.18 | Upgrade
|
| EPS (Diluted) | 0.11 | 0.10 | 0.05 | -0.13 | 0.02 | 0.18 | Upgrade
|
| EPS Growth | 53.14% | 88.12% | - | - | -88.74% | - | Upgrade
|
| Free Cash Flow | 301.87 | 348.04 | 244.55 | 228.6 | 239.67 | -30.9 | Upgrade
|
| Free Cash Flow Per Share | 0.13 | 0.15 | 0.11 | 0.10 | 0.11 | -0.01 | Upgrade
|
| Gross Margin | 52.33% | 53.46% | 58.27% | 56.17% | 73.52% | 72.16% | Upgrade
|
| Operating Margin | 11.46% | 11.99% | 6.55% | 2.76% | 3.68% | -4.74% | Upgrade
|
| Profit Margin | 10.04% | 9.54% | 4.58% | -9.37% | 1.43% | 13.10% | Upgrade
|
| Free Cash Flow Margin | 12.58% | 14.26% | 9.31% | 7.36% | 7.62% | -1.01% | Upgrade
|
| EBITDA | 363.16 | 383.85 | 275.55 | 215.66 | 254.64 | 4.47 | Upgrade
|
| EBITDA Margin | 15.14% | 15.73% | 10.49% | 6.94% | 8.10% | 0.15% | Upgrade
|
| D&A For EBITDA | 88.21 | 91.28 | 103.57 | 130.05 | 138.96 | 149.16 | Upgrade
|
| EBIT | 274.95 | 292.57 | 171.97 | 85.61 | 115.68 | -144.7 | Upgrade
|
| EBIT Margin | 11.46% | 11.99% | 6.55% | 2.76% | 3.68% | -4.74% | Upgrade
|
| Effective Tax Rate | 12.50% | 14.51% | 27.20% | - | 37.38% | 27.68% | Upgrade
|
| Revenue as Reported | - | - | 2,626 | 3,108 | 3,145 | 3,055 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.